chartexchange

EVMN
Evommune, Inc.
stockNYSE

Market OpenNov 19, 2026 9:34:01 AM EST
7.13USD+3.333%(+0.23)5,586
5.4700Bid7.9800Ask2.5100Spread

EVMN Financials

In Q3 FY 2026 (ended ), Evommune, Inc. (EVMN) reported revenue of $0, net income of −$30.88M, operating cash flow of −$25.88M, and assets of $278.3M (filed ).

Loading financial statements…